Major players operating in the global influenza diagnostic market include, Roche Diagnostics,
Becton, Dickinson and Company, Thermo Fisher Scientific, Alere, Quidel Corporation, and
others. Key players in the market are focused on research and development activities in order
to offer diagnostic devices that are cost-effective and efficient. For instance, in 2016, Roche
received the U.S. FDA clearance and Clinical Laboratory Improvement Amendments (CLIA)
waiver for its cobas Influenza A/B & RSV test. The test is used with the cobas Liat system and
assists in molecular testing of flu A/B and RSV.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/influenza-diagnostics-market-2414
Influenza Diagnostic Market Taxonomy:
On the basis of test type, the global influenza diagnostic market is segmented into:
Traditional Diagnostic Tests
Rapid Influenza Diagnostic Tests (RIDT) ,Viral Culture ,Direct Fluorescent Antibody (DFA)
Tests ,Serological Assays
Molecular Diagnostic Assays
RT-PCR ,Nucleic Acid Sequence-Based Amplification (NASBA) Tests ,Loop-Mediated Isothermal
Amplification-Based Assays (LAMP) ,Simple Amplification-Based Assays (SAMBA) ,Others
On the basis of end user, the global influenza diagnostic market is segmented into:
Hospitals & Clinics ,Reference Laboratories ,Others
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights